As a Medicare/Medicare-Medicaid provider, you know that quality health care is a high priority for Fidelis Care and the Centers for Medicare & Medicaid Services (CMS). CMS and the New York State Department of Health consider DMARD use an important quality measure in patients with Rheumatoid Arthritis (RA).
Fidelis Care has posted a tip sheet with information from the Centers for Disease Control (CDC) on the importance of chlamydia screening.
It is an exciting time in the advancement of biosimilar medicines technology and treatments for patients. Over the past few years, great progress has been made in the development and approval of more affordable biosimilar versions of innovative therapies that treat some of the most debilitating and serious health conditions.
As your health care partner, Fidelis Care is notifying you about key changes to how we will manage our members’ benefits for family planning and reproductive health services. These changes will take place on January 1, 2019.
Fidelis Care has made changes to our Medicaid Managed Care, Child Health Plus, and HealthierLife Formulary effective in the 4th quarter 2018. Some of the changes relate to quantity limitations, authorization requirements, as well as drugs being removed and added to the formulary. To review the list and the effective dates, download formulary changes.